300109 新开源
已收盘 10-09 15:00:00
资讯
新帖
简况
新开源：R01（个体化肿瘤新生抗原mRNA疫苗）已获得临床一期批件
证券之星 · 09-16
新开源：R01（个体化肿瘤新生抗原mRNA疫苗）已获得临床一期批件
新开源（300109）披露2026年半年度报告，8月25日股价下跌0.94%
证券之星 · 08-25
新开源（300109）披露2026年半年度报告，8月25日股价下跌0.94%
图解新开源中报：第二季度单季净利润同比下降38.05%
证券之星 · 08-25
图解新开源中报：第二季度单季净利润同比下降38.05%
新开源2026年半年报：经营现金流改善，增收不增利
蓝鲸财经 · 08-25
新开源2026年半年报：经营现金流改善，增收不增利
新开源(300109.SZ)发布上半年业绩，归母净利润1.01亿元，同比下降27.31%
智通财经 · 08-25
新开源(300109.SZ)发布上半年业绩，归母净利润1.01亿元，同比下降27.31%
GLM-5.3以更小参数规模刷新开源最高分，进入全球前沿模型
智通财经 · 08-19
GLM-5.3以更小参数规模刷新开源最高分，进入全球前沿模型
头部厂商密集更新开源模型 押注下一场AI角力赛道
第一财经 · 08-13
头部厂商密集更新开源模型 押注下一场AI角力赛道
新开源：华道生物CAR-T创新药现阶段处于正常推进审评、核查流程阶段
证券之星 · 07-30
新开源：华道生物CAR-T创新药现阶段处于正常推进审评、核查流程阶段
B.AI 平台宣布 Kimi K3 API 正式开放，无缝接入最新开源模型能力
链捕手 · 07-17
B.AI 平台宣布 Kimi K3 API 正式开放，无缝接入最新开源模型能力
亚马逊(AMZN)涨逾3% 推出全新开源模型MCP服务器 汇丰研究指其近期股价表现落后已过度
金吾财讯 · 07-15
亚马逊(AMZN)涨逾3% 推出全新开源模型MCP服务器 汇丰研究指其近期股价表现落后已过度
新开源：VRT106针对肝癌适应症已启动II/III期注册临床试验
证券之星 · 07-14
新开源：VRT106针对肝癌适应症已启动II/III期注册临床试验
新开源（300109）披露控股股东部分股份解除质押及再质押公告，7月8日股价下跌5.69%
证券之星 · 07-08
新开源（300109）披露控股股东部分股份解除质押及再质押公告，7月8日股价下跌5.69%
新开源（300109）股东王东虎质押1716万股，占总股本2.97%
证券之星 · 07-08
新开源（300109）股东王东虎质押1716万股，占总股本2.97%
新开源：公司聚焦主业稳健经营，已于6月10日完成3亿元回购
证券之星 · 06-25
新开源：公司聚焦主业稳健经营，已于6月10日完成3亿元回购
新开源：MLCC产业链中PVP相关产品处于部分客户试样验证阶段
格隆汇 · 06-25
新开源：MLCC产业链中PVP相关产品处于部分客户试样验证阶段
新开源：公司PVP具备分散、粘结、成膜、增溶、络合稳定等核心特性
证券之星 · 06-25
新开源：公司PVP具备分散、粘结、成膜、增溶、络合稳定等核心特性
每周股票复盘：新开源（300109）股东户数减少5.2%
证券之星 · 06-21
每周股票复盘：新开源（300109）股东户数减少5.2%
股市必读：新开源(300109)股东户数1.66万户，较上期减少5.2%
证券之星 · 06-17
股市必读：新开源(300109)股东户数1.66万户，较上期减少5.2%
新开源（300109）披露2025年度利润分配及资本公积金转增股本实施公告，6月16日股价下跌1.24%
证券之星 · 06-16
新开源（300109）披露2025年度利润分配及资本公积金转增股本实施公告，6月16日股价下跌1.24%
新开源：永泰生物是公司参股公司，暂无增资计划
证券之星 · 06-16
新开源：永泰生物是公司参股公司，暂无增资计划
加载更多
公司概况
公司名称：
博爱新开源医疗科技集团股份有限公司
所属行业：
化学原料和化学制品制造业
上市日期：
2010-08-25
主营业务：
博爱新开源医疗科技集团股份有限公司的主营业务是精细化工和精准医疗。公司的主要产品是聚乙烯吡咯烷酮（PVP）系列产品、乙烯基甲醚和马来酸酐共聚物（PVME/MA）系列产品。
发行价格：
30.00
{"stockData":{"symbol":"300109","market":"SZ","secType":"STK","nameCN":"新开源","latestPrice":12.92,"timestamp":1791529380000,"preClose":12.75,"halted":0,"volume":11414200,"delay":0,"changeRate":0.0133,"floatShares":521000000,"shares":577000000,"eps":0.2638,"marketStatus":"已收盘","change":0.17,"latestTime":"10-09 15:00:00","open":12.67,"high":12.98,"low":12.36,"amount":144000000,"amplitude":0.0486,"askPrice":12.93,"askSize":190,"bidPrice":12.92,"bidSize":142,"shortable":0,"etf":0,"ttmEps":0.2638,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791768600000},"marketStatusCode":5,"adr":0,"adjPreClose":12.75,"symbolType":"stock","openAndCloseTimeList":[[1791509400000,1791516600000],[1791522000000,1791529200000]],"highLimit":14.03,"lowLimit":11.48,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":576856526,"isCdr":false,"pbRate":2.2,"roa":"--","peRate":48.976497,"roe":"2.72%","epsLYR":0.39,"committee":-0.45641,"marketValue":7453000000,"turnoverRate":0.0219,"status":0,"floatMarketCap":6730000000},"requestUrl":"/m/hq/s/300109","defaultTab":"news","newsList":[{"id":"2667671749","title":"新开源：R01（个体化肿瘤新生抗原mRNA疫苗）已获得临床一期批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2667671749","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667671749?lang=zh_cn&edition=full","pubTime":"2026-09-16 11:36","pubTimestamp":1789529788,"startTime":"0","endTime":"0","summary":"证券之星消息，新开源(300109)09月15日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司投资的杭州纽安津研发的MRNA疫苗目前有没新的进展？新开源回复：您好，公司参股公司纽安津首发管线注射用P01（个体化肿瘤新生抗原多肽疫苗）于2023年先后取得中国和美国临床一期批件，截至2026年7月已完成中国临床一期试验，并已开始临床二期，R01（个体化肿瘤新生抗原mRNA疫苗）已获得临床一期批件。谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091600014589.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300109","BK0046","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662956758","title":"新开源（300109）披露2026年半年度报告，8月25日股价下跌0.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662956758","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662956758?lang=zh_cn&edition=full","pubTime":"2026-08-25 22:13","pubTimestamp":1787667212,"startTime":"0","endTime":"0","summary":"截至2026年8月25日收盘，新开源报收于15.8元，较前一交易日下跌0.94%，最新总市值为91.14亿元。该股当日开盘15.67元，最高15.99元，最低15.2元，成交额达5.3亿元，换手率为6.54%。近日，博爱新开源医疗科技集团股份有限公司披露《2026年半年度报告》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500050400.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300109","BK0046","BK0042","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662733296","title":"图解新开源中报：第二季度单季净利润同比下降38.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662733296","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662733296?lang=zh_cn&edition=full","pubTime":"2026-08-25 18:12","pubTimestamp":1787652759,"startTime":"0","endTime":"0","summary":"证券之星消息，新开源2026年中报显示，上半年度公司主营收入6.78亿元，同比上升5.29%；归母净利润1.01亿元，同比下降27.31%；扣非净利润1.11亿元，同比下降13.97%；其中2026年第二季度，公司单季度主营收入3.36亿元，同比上升5.3%；单季度归母净利润3626.27万元，同比下降38.05%；单季度扣非净利润4823.11万元，同比下降19.48%；负债率22.46%，财务费用176.53万元，毛利率39.31%。财报数据概要请见下图:本文数据来源于新开源2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500038607.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300109"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662780110","title":"新开源2026年半年报：经营现金流改善，增收不增利","url":"https://stock-news.laohu8.com/highlight/detail?id=2662780110","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662780110?lang=zh_cn&edition=full","pubTime":"2026-08-25 17:19","pubTimestamp":1787649583,"startTime":"0","endTime":"0","summary":"蓝鲸新闻8月25日讯，8月25日，新开源 公布2026年中报，公司依托精细化工与精准医疗双主业协同运营，受制于核心产品PVP阶段性价格调整及公允价值变动损失影响，报告期呈现“增收不增利”态势；同时，经营活动现金流显著改善，股份回购注销完成推动股本结构优化。财报数据显示，报告期公司实现营业收入6.78亿元，同比增长5.29%；归母净利润1.01亿元，同比下降27.31%；扣非净利润1.11亿元，同比下降13.97%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1787645346248321352","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["300109","SPHQ","BK0229","159399","BK4585","BK0046","BK4588","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662824587","title":"新开源(300109.SZ)发布上半年业绩，归母净利润1.01亿元，同比下降27.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662824587","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662824587?lang=zh_cn&edition=full","pubTime":"2026-08-25 16:37","pubTimestamp":1787647046,"startTime":"0","endTime":"0","summary":"智通财经APP讯，新开源(300109.SZ)发布2026年半年度报告，报告期内，公司实现营业收入6.78亿元，同比增长5.29%。实现归属于上市公司股东的净利润1.01亿元，同比下降27.31%。实现归属于上市公司股东的扣除非经常性损益的净利润1.11亿元，同比下降13.97%。报告期业绩变动的主要原因：产品价格波动影响：报告期内，公司精细化工板块持续开拓新产品、新市场，稳步稳固市场份额。受核心产品PVP 阶段性价格调整影响，毛利率产生波动，对公司经营业绩造成一定影响。截至报告期末，PVP产品价格已趋于稳定，相关不利影响将逐步消除。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1484998.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"新开源(300109.SZ)发布上半年业绩，归母净利润1.01亿元，同比下降27.31%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300109"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660413711","title":"GLM-5.3以更小参数规模刷新开源最高分，进入全球前沿模型","url":"https://stock-news.laohu8.com/highlight/detail?id=2660413711","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660413711?lang=zh_cn&edition=full","pubTime":"2026-08-19 09:01","pubTimestamp":1787101300,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，8月19日凌晨，智谱正式上线新一代基座模型GLM-5.3的API。值得关注的是，GLM-5.3以更小的参数规模、更高的参数效率和更低的调用成本达到前沿模型水平，并且在同等智能下，其单任务成本为前沿旗舰模型中最低，将\"智能—成本\"的帕累托前沿显著推进，进一步拓展前沿智能的应用边界。模型已接入ZCode、GLM Coding Plan等智谱产品，API定价与GLM-5.2保持一致，完整模型权重计划于下周五以负责任的方式开源。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1481727.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02513","BK0046","BK0042","300109","BK1117","BK0229","LU0593848301.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659018777","title":"头部厂商密集更新开源模型 押注下一场AI角力赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2659018777","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659018777?lang=zh_cn&edition=full","pubTime":"2026-08-13 11:20","pubTimestamp":1786591205,"startTime":"0","endTime":"0","summary":"【头部厂商密集更新开源模型 押注下一场AI角力赛道】8月13日，DeepSeekV4Pro正式版上线，阿里正式开放Qwen3.8-2.4T-A95B模型权重，也是阿里首次将Max级旗舰模型对外开放权重。几天前，Meta发布开源模型MuseGlimmer，并预告将开放旗舰模型MuseSpark1.2权重。头部厂商密集更新开源模型并非孤立事件。过去数周，Kimi K3、智谱GLM-5.2、Minimax H3等国产模型相继迭代，已然勾画出一条清晰的开源加速曲线。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608133840242453.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608133840242453.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["CHAT","AGIX","VTHR","BK0046","AIPO","300109","BK0042","BK0229","ARTY","QTOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655482123","title":"新开源：华道生物CAR-T创新药现阶段处于正常推进审评、核查流程阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2655482123","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655482123?lang=zh_cn&edition=full","pubTime":"2026-07-30 16:27","pubTimestamp":1785400029,"startTime":"0","endTime":"0","summary":"证券之星消息，新开源(300109)07月30日在投资者关系平台上答复投资者关心的问题。投资者提问：公司参股的华道生物的car-t细胞药大概什么时候能上市？新开源回复：您好，华道生物CAR-T创新药现阶段处于正常推进审评、核查流程阶段，谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073000025626.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300109","06978","BK0229","BK1574","BK0046","159992","BK1161","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652060014","title":"B.AI 平台宣布 Kimi K3 API 正式开放，无缝接入最新开源模型能力","url":"https://stock-news.laohu8.com/highlight/detail?id=2652060014","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652060014?lang=zh_cn&edition=full","pubTime":"2026-07-17 16:49","pubTimestamp":1784278163,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，B.AI 宣布 Kimi K3 模型正式上线其 API 平台，在 @Kimi_Moonshot 发布后即完成无缝接入。作为全球首个开源 3T 级（2.8万亿参数）模型，Kimi K3 在长程编程、复杂推理及知识工作领域实现重大突破，并原生支持视觉能力与 1M 超长上下文。作为模型聚合服务平台，B.AI 本次优先开放 API 接口，开发者现可通过 B.AI 直接体验新一代模型能力。B.AI 将持续以高效、稳定的接口服务，推动前沿 AI 技术快速落地，赋能开发者创新。 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2276971","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0229","BK0046","OTX.SI","300109","BK6520","BK0042","BK6100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651612744","title":"亚马逊(AMZN)涨逾3% 推出全新开源模型MCP服务器 汇丰研究指其近期股价表现落后已过度","url":"https://stock-news.laohu8.com/highlight/detail?id=2651612744","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651612744?lang=zh_cn&edition=full","pubTime":"2026-07-15 22:42","pubTimestamp":1784126523,"startTime":"0","endTime":"0","summary":"金吾财讯 | 亚马逊 股价持续上扬，暂报254.99美元，涨幅3.03%。消息面上，亚马逊云科技近日在日内瓦举办的联合国国际电信联盟“人工智能向善”全球峰会上，宣布推出全新的开源模型上下文协议服务器。该行指，亚马逊在AI需求强劲成长以及核心云端服务增长的展望下，定位良好，近期股价表现落后已过度。","market":"us","thumbnail":"https://static.szfiu.com/news/20250107/ZDBhOTg3YTMxNzM2MjM3OTI3ODI2.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/ZDBhOTg3YTMxNzM2MjM3OTI3ODI2.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302618","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4596","OGIG","USAW.SI","AMZD","HSBC","HK0000304805.HKD","LU2065171402.SGD","300109","GOOG","AMZN","BK0042","AAPL","IE00B4JS1V06.HKD","LU1548497426.USD","META","AZYY","LU2211817866.USD","VERS","LU0314104364.USD","CLIX","BULZ","BK4592","WANT","LU2236285917.USD","RTH","LU1267930573.SGD","IE00BFXG0V08.USD","MAGY","YMAG","WTAI","IE00B7SZLL34.SGD","AMZW","LU1935042488.USD","AMZU","SGXZ81514606.USD","ILDR","ONLN","SG9999002232.USD","AMZY","LU2106854487.HKD","LU1861559042.SGD","AMZZ","HSBH","LU1066051811.HKD","LU1201861249.SGD","TSLA","NVDA","MSFT","AMZP","LU0820561909.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651128129","title":"新开源：VRT106针对肝癌适应症已启动II/III期注册临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2651128129","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651128129?lang=zh_cn&edition=full","pubTime":"2026-07-14 09:01","pubTimestamp":1783990875,"startTime":"0","endTime":"0","summary":"证券之星消息，新开源(300109)07月13日在投资者关系平台上答复投资者关心的问题。投资者提问：公司参股的广州威溶特公司目前创新药有什么进展是否可以详细介绍一下这企业目前的经营情况？新开源回复：您好，公司参股广州威溶特，目前持股比例约 8.17%。其核心在研产品 VRT106 针对肝癌适应症已启动 II/III 期注册临床试验，且该产品已通过海南博鳌乐城先行区项目遴选，后续将围绕肝癌适应症开展真实世界研究。谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400008548.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","300109","BK0229","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649072991","title":"新开源（300109）披露控股股东部分股份解除质押及再质押公告，7月8日股价下跌5.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2649072991","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649072991?lang=zh_cn&edition=full","pubTime":"2026-07-08 22:17","pubTimestamp":1783520236,"startTime":"0","endTime":"0","summary":"截至2026年7月8日收盘，新开源报收于14.41元，较前一交易日下跌5.69%，最新总市值为83.13亿元。博爱新开源医疗科技集团股份有限公司于2026年7月8日发布公告，公司控股股东、实际控制人之一王东虎先生将其持有的18,240,000股股份解除质押，并将17,160,000股股份重新质押给中国银河证券股份有限公司，用于个人融资。本次解除质押及再质押后，王东虎先生持有公司股份50,514,266股，占公司总股本的8.76%，其累计质押股份由27,240,000股减少至26,160,000股，占其所持股份比例由38.66%降至37.13%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070800042658.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","300109","BK0229","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649967094","title":"新开源（300109）股东王东虎质押1716万股，占总股本2.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2649967094","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649967094?lang=zh_cn&edition=full","pubTime":"2026-07-08 18:27","pubTimestamp":1783506439,"startTime":"0","endTime":"0","summary":"证券之星消息，新开源（300109）7月8日公开信息显示，股东王东虎向中国银河证券股份有限公司合计质押1716.0万股，占总股本2.97%。质押详情见下表：新开源财务数据及主营业务：新开源2026年一季报显示，一季度公司主营收入3.42亿元，同比上升5.29%；归母净利润6475.02万元，同比下降19.49%；扣非净利润6302.2万元，同比下降9.21%；负债率15.2%，财务费用723.02万元，毛利率43.52%。新开源（300109）主营业务：精细化工和精准医疗。本文数据来源于新开源公告，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070800035713.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0046","BK0229","300109"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646803892","title":"新开源：公司聚焦主业稳健经营，已于6月10日完成3亿元回购","url":"https://stock-news.laohu8.com/highlight/detail?id=2646803892","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646803892?lang=zh_cn&edition=full","pubTime":"2026-06-25 20:51","pubTimestamp":1782391912,"startTime":"0","endTime":"0","summary":"证券之星消息，新开源(300109)06月24日在投资者关系平台上答复投资者关心的问题。投资者提问：创业板指数上涨了1700点，公司回购了3亿逆市股价却下跌了15%，请问公司高管是否考虑增持增强市场信心？新开源回复：您好，公司聚焦主业稳健经营，已于6月10日完成3亿元回购，二级市场股价受多重因素影响，后续公司将结合股价实际情况，统筹研判包括高管增持在内的多种市值维护举措，切实维护全体股东利益。谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062500041719.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300109","BK0042","BK0046","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646847009","title":"新开源：MLCC产业链中PVP相关产品处于部分客户试样验证阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2646847009","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646847009?lang=zh_cn&edition=full","pubTime":"2026-06-25 09:09","pubTimestamp":1782349779,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0042","BK0046","BK0229","300109"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646578840","title":"新开源：公司PVP具备分散、粘结、成膜、增溶、络合稳定等核心特性","url":"https://stock-news.laohu8.com/highlight/detail?id=2646578840","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646578840?lang=zh_cn&edition=full","pubTime":"2026-06-25 09:09","pubTimestamp":1782349751,"startTime":"0","endTime":"0","summary":"证券之星消息，新开源(300109)06月24日在投资者关系平台上答复投资者关心的问题。投资者提问：公司的高纯度pvp在MLCC领域目前出货量是否未来有比较大幅度的增长？新开源回复：回复：公司PVP具备分散、粘结、成膜、增溶、络合稳定等核心特性，产品广泛应用于医药、日化、食品、传统涂料化工、新能源等多个领域。在 MLCC产业链中，PVP一方面用于上游内电极镍粉、外电极铜粉制备过程中的分散助剂，另一方面在瓷浆制备工序中用作粉体分散材料。现阶段相关产品处于部分客户试样验证阶段，谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062500007710.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300109","BK0046","BK0042","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645095923","title":"每周股票复盘：新开源（300109）股东户数减少5.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645095923","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645095923?lang=zh_cn&edition=full","pubTime":"2026-06-21 01:59","pubTimestamp":1781978348,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，新开源报收于18.62元，较上周的17.4元上涨7.01%。本周关注点股本股东变化：截至2026年6月10日股东户数为1.66万户，较前期减少5.2%。公司公告汇总关于2025年度利润分配及资本公积金转增股本实施公告公司以总股本483,380,605股剔除已回购股份16,001,000股后的基数，向全体股东每10股派发现金红利2.00元（含税），合计派发93,475,921.00元（含税）；同时以资本公积金每10股转增2股，合计转增93,475,921股。本次转增后总股本将增至576,856,526股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062100000455.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300109","BK0046","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644258761","title":"股市必读：新开源(300109)股东户数1.66万户，较上期减少5.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2644258761","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644258761?lang=zh_cn&edition=full","pubTime":"2026-06-17 01:32","pubTimestamp":1781631131,"startTime":"0","endTime":"0","summary":"截至2026年6月16日收盘，新开源报收于17.49元，下跌1.24%，换手率1.33%，成交量5.75万手，成交额1.01亿元。股本股东变化股东户数变动截至2026年6月10日公司股东户数为1.66万户，较5月29日减少910.0户，减幅为5.2%；户均持股数量由上期的2.76万股增加至2.91万股，户均持股市值为49.42万元。董秘： 您好，截至6月10日收市，公司股东户数合并约为16,600户，谢谢！投资者： 你好董秘，截止2026年6月10日股东人数多少？","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061700000589.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0046","300109","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643758022","title":"新开源（300109）披露2025年度利润分配及资本公积金转增股本实施公告，6月16日股价下跌1.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2643758022","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2643758022?lang=zh_cn&edition=full","pubTime":"2026-06-16 17:40","pubTimestamp":1781602838,"startTime":"0","endTime":"0","summary":"截至2026年6月16日收盘，新开源报收于17.49元，较前一交易日下跌1.24%，最新总市值为84.54亿元。公告显示，公司2025年度利润分配及资本公积金转增股本方案已获2026年5月15日年度股东大会审议通过。公司以总股本483,380,605股剔除已回购的16,001,000股后为基数，向全体股东每10股派发现金红利2.00元（含税），合计派发现金93,475,921.00元（含税）；同时以资本公积金每10股转增2股，合计转增93,475,921股。本次转增后公司总股本将增至576,856,526股。回购股份不参与本次权益分派。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600031813.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0046","BK0229","300109"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643948734","title":"新开源：永泰生物是公司参股公司，暂无增资计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2643948734","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2643948734?lang=zh_cn&edition=full","pubTime":"2026-06-16 15:30","pubTimestamp":1781595032,"startTime":"0","endTime":"0","summary":"证券之星消息，新开源(300109)06月16日在投资者关系平台上答复投资者关心的问题。投资者提问：永泰生物的创新药需要补充三期临床数据，而永泰生物净资产已经是负数了，现金流没有了公司会否考虑增资解决子公司的危机？新开源回复：您好，永泰生物是公司参股公司，暂无增资计划，谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600021597.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300109","BK0046","BK0042"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1791595032251,"stockEarnings":[{"period":"1week","weight":0.0031},{"period":"1month","weight":-0.0408},{"period":"3month","weight":-0.0811},{"period":"6month","weight":-0.1467},{"period":"1year","weight":-0.1198},{"period":"ytd","weight":-0.072}],"compareEarnings":[{"period":"1week","weight":-0.0074},{"period":"1month","weight":-0.0349},{"period":"3month","weight":-0.0456},{"period":"6month","weight":-0.0433},{"period":"1year","weight":-0.0305},{"period":"ytd","weight":-0.0391}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"博爱新开源医疗科技集团股份有限公司","boardCode":"AI0026","boardName":"化学原料和化学制品制造业","stockholders":"17460人(较上一季度增加5.18%)","perCapita":"29832股","listingDate":"2010-08-25","address":"河南省焦作市博爱县文化路(东段)1888号","registeredCapital":"57685万元","survey":" 博爱新开源医疗科技集团股份有限公司的主营业务是精细化工和精准医疗。公司的主要产品是聚乙烯吡咯烷酮（PVP）系列产品、乙烯基甲醚和马来酸酐共聚物（PVME/MA）系列产品。","listedPrice":30},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"新开源(300109)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供新开源(300109)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"新开源,300109,新开源股票,新开源股票老虎,新开源股票老虎国际,新开源行情,新开源股票行情,新开源股价,新开源股市,新开源股票价格,新开源股票交易,新开源股票购买,新开源股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"新开源(300109)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供新开源(300109)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}